Daniel Schulz

Daniel Schulz

Auto-generated profile, based on publicly available information

Daniel Schulz

Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2023 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JWJonas Windhager
Jonas Windhager
VZVito Riccardo Tomaso Zanotelli
Vito Riccardo Tomaso Zanotelli
DSDaniel Schulz
Daniel Schulz
LMLasse Meyer
Lasse Meyer
MDMichelle Daniel
Michelle Daniel
NENils Eling
Nils Eling

1 November 2013 in Cell
Verified
Journal Article
Closed access
DSDaniel Schulz
Daniel Schulz
BSBjoern Schwalb
Bjoern Schwalb
AKAnja Kiesel
Anja Kiesel
CBCarlo Baejen
Carlo Baejen
PTPhillipp Torkler
Phillipp Torkler
PCPatrick Cramer
Patrick Cramer

15 April 2022 in Science Immunology
Verified
Journal Article
Closed access
THTobias Hoch
Tobias Hoch
DSDaniel Schulz
Daniel Schulz
NENils Eling
Nils Eling
JGJulia Martínez Gómez
Julia Martínez Gómez
MLMitchell Levesque
Mitchell Levesque
BBBernd Bodenmiller
Bernd Bodenmiller
Intratumoral immune cells are crucial for tumor control and antitumor responses during immunotherapy. Immune cell trafficking into tumors is mediated by binding of specific immune cell receptors to chemokines, a class of secreted chemotactic cytokines. To broadly characterize chemokine expression and function in melanoma, we used multiplexed mass cytometry–based imaging of protein markers and RNA transcripts to analyze the chemokine landscape and immune infiltration in metastatic melanoma samples. Tumors that lacked immune infiltration were devoid of most of the profiled chemokines and exhibited low levels of antigen presentation and markers of inflammation. Infiltrated tumors were characterized by expression of multiple chemokines. CXCL9 and CXCL10 were often localized in patches associated with dysfunctional T cells expressing the B lymphocyte chemoattractant CXCL13. In tumors with B cells but no B cell follicles, T cells were the sole source of CXCL13 , suggesting that T cells play a role in B cell recruitment and potentially in B cell follicle formation. B cell patches and follicles were also enriched with TCF7 + naïve-like T cells, a cell type that is predictive of response to immune checkpoint blockade. Our data highlight the strength of targeted RNA and protein codetection to analyze tumor immune microenvironments based on chemokine expression and suggest that the formation of tertiary lymphoid structures may be accompanied by naïve and naïve-like T cell recruitment, which may contribute to antitumor activity.

1 June 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DSDaniel Schulz
Daniel Schulz
NPNicole Pirkl
Nicole Pirkl
ELElisabeth Lehmann
Elisabeth Lehmann
PCPatrick Cramer
Patrick Cramer
RNA polymerase II (Pol II) is the central enzyme that carries out eukaryotic mRNA transcription and consists of a 10-subunit catalytic core and a subcomplex of subunits Rpb4 and Rpb7 (Rpb4/7). Rpb4/7 has been proposed to dissociate from Pol II, enter the cytoplasm, and function there in mRNA translation and degradation. Here we provide evidence that Rpb4 mainly functions in nuclear mRNA synthesis by Pol II, as well as evidence arguing against an important cytoplasmic role in mRNA degradation. We used metabolic RNA labeling and comparative Dynamic Transcriptome Analysis to show that Rpb4 deletion in Saccharomyces cerevisiae causes a drastic defect in mRNA synthesis that is compensated by down-regulation of mRNA degradation, resulting in mRNA level buffering. Deletion of Rpb4 can be rescued by covalent fusion of Rpb4 to the Pol II core subunit Rpb2, which largely restores mRNA synthesis and degradation defects caused by Rpb4 deletion. Thus, Rpb4 is a bona fide Pol II core subunit that functions mainly in mRNA synthesis.

11 December 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JKJörg Klufa
Jörg Klufa
TBThomas Bauer
Thomas Bauer
BHBuck Hanson
Buck Hanson
CHCraig Herbold
Craig Herbold
PSPhilipp Starkl
Philipp Starkl
MSMaria Sibilia
Maria Sibilia
EGFR/ERK signaling in Lrig1 + stem cells secures barrier integrity during hair eruption to protect from invasion of commensal microbiota.

30 December 2022 in Nature Methods
Verified
Journal Article
Open access
PDF file
PBPierre Bost
Pierre Bost
DSDaniel Schulz
Daniel Schulz
SEStefanie Engler
Stefanie Engler
CWClive Wasserfall
Clive Wasserfall
BBBernd Bodenmiller
Bernd Bodenmiller
Recent advances in multiplexed imaging methods allow simultaneous detection of dozens of proteins and hundreds of RNAs, enabling deep spatial characterization of both healthy and diseased tissues. Parameters for the design of optimal multiplex imaging studies, especially those estimating how much area has to be imaged to capture all cell phenotype clusters, are lacking. Here, using a spatial transcriptomic atlas of healthy and tumor human tissues, we developed a statistical framework that determines the number and area of fields of view necessary to accurately identify all cell phenotypes that are part of a tissue. Using this strategy on imaging mass cytometry data, we identified a measurement of tissue spatial segregation that enables optimal experimental design. This strategy will enable an improved design of multiplexed imaging studies.